data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Gain Therapeutics
(NASDAQ:GANX)
4.13
-0.07[-1.67%]
Last update: 10:24AM
15 minutes delayed
Day High/Low4.04 - 4.2
52 Week High/Low2.33 - 10.77
Open / Close4.2 / -
Float / Outstanding10.8M / 11.9M
Vol / Avg.6.6K / 164.7K
Mkt Cap49.1M
P/E-
50d Avg. Price3.3
Div / Yield-
Payout Ratio-
EPS-0.26
Total Float10.8M

Gain Therapeutics (NASDAQ:GANX), Quotes and News Summary

Gain Therapeutics (NASDAQ: GANX)

Day High/Low4.04 - 4.2
52 Week High/Low2.33 - 10.77
Open / Close4.2 / -
Float / Outstanding10.8M / 11.9M
Vol / Avg.6.6K / 164.7K
Mkt Cap49.1M
P/E-
50d Avg. Price3.3
Div / Yield-
Payout Ratio-
EPS-0.26
Total Float10.8M
Benzinga - Sponsored
Benzinga - May 23, 2022, 2:01PM
Benzinga - May 16, 2022, 4:38PM
Benzinga - May 11, 2022, 9:32AM
Benzinga - May 6, 2022, 8:06AM
Benzinga - Apr 12, 2022, 1:30PM
Benzinga - Apr 12, 2022, 1:26PM
Benzinga - Apr 12, 2022, 1:20PM
Benzinga - Apr 12, 2022, 1:16PM
Benzinga - Apr 12, 2022, 1:01PM
Benzinga - Mar 29, 2022, 8:08AM
Benzinga - Mar 29, 2022, 7:33AM
Benzinga - Mar 29, 2022, 6:12AM
Benzinga - Mar 24, 2022, 8:08AM
Benzinga - Mar 15, 2022, 12:08PM
Benzinga - Mar 15, 2022, 8:11AM
Benzinga - Feb 8, 2022, 8:04AM
Benzinga - Feb 4, 2022, 12:09PM
Benzinga - Nov 12, 2021, 9:56AM
Benzinga - Nov 12, 2021, 7:20AM
Benzinga - Nov 10, 2021, 12:38PM
Benzinga - Nov 3, 2021, 5:00AM
load more
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.370-0.280 0.0900
REV40.000K45.000K5.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Gain Therapeutics Questions & Answers

Q
How do I buy Gain Therapeutics (GANX) stock?
A

You can purchase shares of Gain Therapeutics (NASDAQ: GANX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Gain Therapeutics's (GANX) competitors?
A

There are no as such competitors for Gain Therapeutics.

Q
What is the target price for Gain Therapeutics (GANX) stock?
A

The latest price target for Gain Therapeutics (NASDAQ: GANX) was reported by B. Riley Securities on Tuesday, March 29, 2022. The analyst firm set a price target for 16.00 expecting GANX to rise to within 12 months (a possible 287.41% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Gain Therapeutics (GANX)?
A

The stock price for Gain Therapeutics (NASDAQ: GANX) is $4.13 last updated Today at June 28, 2022, 2:24 PM UTC.

Q
Does Gain Therapeutics (GANX) pay a dividend?
A

There are no upcoming dividends for Gain Therapeutics.

Q
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
A

Gain Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Gain Therapeutics (GANX) going to split?
A

There is no upcoming split for Gain Therapeutics.

Q
What sector and industry does Gain Therapeutics (GANX) operate in?
A

Gain Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.